The CDC, prior to Kennedy opening his mouth, recommended that Americans older than 6 months get an annual coronavirus vaccine. There is evidence supporting the importance of pregnant women being ...

Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.

Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ...

The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and Prevention — but a new study from Cleveland Clinic suggests that it might ...

The MMR vaccine is highly effective. Most vaccinated people will not develop measles, mumps or rubella when they are exposed to the diseases. But, in the case a vaccinated person does develop one ...

A flu vaccine at a mobile vaccination and testing clinic in San Francisco in 2020. Credit... Jim Wilson/The New York Times. By Teddy Rosenbluth. May 16, 2025.

FDA to issue new vaccine approval guidance amid questions over coronavirus shots. FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A cardiologist shares insights on the findings.

Moderna MRNA 3.58 % increase; green up pointing triangle was once a darling of the first Trump administration, which went to great lengths to help the company develop its Covid-19 vaccine that ...

Moderna’s mRNA-based flu and covid-19 vaccine could provide the best of both worlds—if it’s actually ever approved by the Food and Drug Administration.

Now that measles, which was declared eliminated from the U.S. in 2000, has re-emerged, you may be wondering about: whether you should get a measles vaccine booster.

The vaccine is meant to prevent a common infection in adults over 50. One version of it, which was studied in the new research, was discontinued in the US in 2020.